Format

Send to

Choose Destination
Nat Rev Cancer. 2006 May;6(5):360-8.

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

Author information

1
Department of Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100083, China. Jason@bjmu.edu.cn

Abstract

Endometrial cancer is the most common gynaecological cancer, and is associated with endometrial hyperplasia, unopposed oestrogen exposure and adjuvant therapy for breast cancer using selective oestrogen-receptor modulators (SERMs), particularly tamoxifen. Oestrogen and SERMs are thought to be involved in endometrial carcinogenesis through their effects on transcriptional regulation. Ultimately, oestrogen and SERMs affect the transduction of cellular signalling pathways that govern cell growth and proliferation, through downstream effectors such as PAX2 (paired box 2).

PMID:
16633364
DOI:
10.1038/nrc1879
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center